Mobile Integrated Health for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods to assist people with heart failure after hospital discharge. One group receives phone check-ins from a Transitions of Care Coordinator, while the other has access to a community paramedic through Mobile Integrated Health, who can visit their home and connect them with an emergency doctor via video if needed. The trial aims to determine which method more effectively reduces hospital readmissions and improves quality of life. Individuals currently hospitalized for heart failure in New York City with Medicare or Medicaid may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative care strategies and potentially improve health outcomes.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but you should confirm with the trial coordinators.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these care methods are safe for patients with heart failure?
Research has shown that Mobile Integrated Health (MIH) and community paramedicine programs can benefit patients after hospital discharge. In these programs, trained paramedics visit patients at home to check vital signs, perform physical exams, and ensure home safety. They can also connect with doctors through video calls if needed.
Most studies focus on how these programs help prevent hospital readmissions and improve quality of life. However, detailed information about safety is limited. Few reports of serious side effects suggest that these programs are generally safe.
These programs have been used in similar situations without major safety issues, indicating they are likely safe for most patients. However, discussing any concerns with a doctor before joining a trial is always important.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Integrated Health (MIH) approach for heart failure because it brings healthcare directly to patients' homes through community paramedics. Unlike traditional treatments that often require frequent visits to clinics or hospitals, MIH offers a personalized, in-home care experience that includes a comprehensive health assessment and medication adjustments via telemedicine with an emergency physician. This innovative method not only enhances accessibility but also aims to reduce hospital readmissions by ensuring continuous and convenient care. Additionally, the Transitions of Care Coordinator (TOCC) provides crucial follow-up support through phone calls, addressing patients' clinical and social needs shortly after hospital discharge, which is a proactive step to prevent complications. These approaches collectively offer a more integrated and patient-centered care model, which could greatly improve outcomes for individuals with heart failure.
What evidence suggests that this trial's treatments could be effective for reducing hospital readmissions in heart failure patients?
Research has shown that Mobile Integrated Health (MIH), one of the treatment arms in this trial, can assist people with heart failure by providing home care, potentially improving recovery. Some studies have found that community paramedic visits to patients' homes can help predict and possibly reduce the likelihood of hospital readmissions within 30 days. While one program did not observe a significant decrease in hospital returns, another study suggested that MIH can facilitate the transition from hospital to home care and might enhance patient health. This approach allows for quick medical assistance and adjustments to treatment plans without requiring a hospital visit. Overall, MIH aims to smooth recovery and possibly reduce the need for hospital readmission.25678
Who Is on the Research Team?
Leah Shafran Topaz, BPT, MSc
Principal Investigator
Weill Medical College of Cornell University
Ruth M. Masterson Creber, PhD, MSc, RN
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for Medicare or Medicaid recipients with heart failure in NYC (Manhattan, Brooklyn, Queens, Bronx) who are getting out of the hospital. It's not for those who don't speak English, Spanish, Mandarin, or French; have dementia/psychosis; will go to/receive care from a nursing facility/rehab/hospice; or await a heart transplant/LVAD.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Mobile Integrated Health or Transitions of Care Coordinator interventions after hospital discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mobile Integrated Health
- Transitions of Care Coordinator
Mobile Integrated Health is already approved in United States for the following indications:
- Congestive Heart Failure
- Chronic Obstructive Pulmonary Disease (COPD)
- Pneumonia
- Cellulitis
- Dehydration
- COVID-19
- Behavioral Health Conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Weill Medical College of Cornell University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator